Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Avient (AVNT)

Avient Q3 adjusted EPS rises 8% to $0.70; sales dip 1%, EBITDA guidance trimmed

Mixed Impact 3 of 5 earnings Written later

Avient reported third quarter 2025 sales of $806.5 million, down from $815.2 million a year earlier, and GAAP EPS of $0.36 versus $0.41. Adjusted EPS rose to $0.70 from $0.65, and the company kept its full-year adjusted EPS guidance of $2.77 to $2.87, while narrowing its full-year adjusted EBITDA guidance to $540 million to $550 million. Shareholders get a mixed picture: profit on an adjusted basis improved and debt is being reduced, but sales fell and the EBITDA range was lowered.

Key points

  • Q3 sales of $806.5 million vs. $815.2 million in Q3 2024, a decline of about 1%
  • Q3 GAAP EPS of $0.36 vs. $0.41; adjusted EPS of $0.70 vs. $0.65, including a $0.02 favorable foreign exchange impact
  • Full-year 2025 adjusted EPS guidance maintained at $2.77 to $2.87; adjusted EBITDA guidance updated to $540 million to $550 million
  • Debt repayment of $50 million in Q3 brought the year-to-date total to $100 million, with $150 million expected for full-year 2025

The filing

CompanyAvient (AVNT)
Form8-K, current report
Filed with the SECNov 5, 2025, 6:01 AM ET
Accession number0001122976-25-000086

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.